Natural Medicine Research Center, Korea Research Institute of Bioscience and Biotechnology, 30 Yeongudanji-ro, Ochang-eup, Cheongwon-gun, Chungbuk 363-883, Republic of Korea.
Food Chem Toxicol. 2012 Nov;50(11):4042-50. doi: 10.1016/j.fct.2012.08.037. Epub 2012 Aug 25.
α- and γ-Mangostin, which are the major xanthones purified from a Mangosteen, Garcinia mangostana Linn., exhibit a wide range of anticancer, antioxidant, and anti-inflammatory activities. Here, we assessed their therapeutic effects in a mouse model of ovalbumin (OVA)-induced allergic asthma. Animals were treated with α- and γ-mangostins orally for 3 days at doses of 10 and 30 mg/kg daily, 1h before the OVA challenge. Administration of α- and γ-mangostins significantly reduced the major pathophysiological features of allergic asthma, including inflammatory cell recruitment into the airway, airway hyperresponsiveness (AHR), and increased levels of Th2 cytokines. In addition, α- and γ-mangostins attenuated the increases in phosphoinositide 3-kinase (PI3K) activity, phosphorylation of Akt, and NF-κB in nuclear protein extracts after OVA challenge. In conclusion, α- and γ-mangostin may have therapeutic potential for the treatment of allergic asthma.
α-和γ-倒捻子素是从藤黄科藤黄属植物山竹中分离得到的主要的氧杂蒽酮类化合物,具有广泛的抗癌、抗氧化和抗炎活性。在这里,我们评估了它们在卵清蛋白(OVA)诱导的变应性哮喘小鼠模型中的治疗作用。动物在 OVA 攻击前 1 小时每天经口给予 α-和 γ-倒捻子素 10 和 30mg/kg 的剂量治疗 3 天。α-和 γ-倒捻子素可显著减轻变应性哮喘的主要病理生理特征,包括气道中炎性细胞的募集、气道高反应性(AHR)和 Th2 细胞因子水平的增加。此外,α-和 γ-倒捻子素可减轻 OVA 攻击后核蛋白提取物中磷酸肌醇 3-激酶(PI3K)活性、Akt 磷酸化和 NF-κB 的增加。总之,α-和 γ-倒捻子素可能具有治疗变应性哮喘的潜力。